RNA Fusion
Gene fusions often act as oncogenic driver mutations in a wide variety of cancer types. Their rapid and accurate detection can inform clinical actions and drive treatment decisions. The Twist Alliance CeGaT RNA Fusion Panel Kit is an RNA-based enrichment panel and offers an improved targeted and sensitive approach to investigate gene fusions than the conventional methods.
This panel includes 160 fusion genes associated with approximately 30 cancer types. The fusion genes were selected by CeGaT, a leading genetic diagnostic and sequencing company located in Europe. The design is not only for the detection of known gene fusions but is also used to identify novel gene fusions.
The panel is optimized and validated for use with the Twist RNA Library Prep Kit for a complete end-to-end workflow exceptional performance. High capture efficiency with the RNA-based enrichment increases the sensitivity of detection. This panel is ideal for screening oncology samples to inform treatment options or discover novel fusions for tumor classifications.*

Panel Design
- 160 fusion associated genes with 66 genes in the breakpoint design
- 7394 Probes
- Covers a variety of different cancer types
* Note: The Twist Alliance CeGaT RNA Fusion Panel – 3 MB is ISO-13485 certified.
What Scientists Have to Say
RNA Fusion
At CeGaT, we want to offer comprehensive and affordable tumor diagnostics to our clients. The Twist Target Enrichment technology is a robust workflow allowing us to accurately analyze patient samples with more than 80 therapeutically actionable fusion variants in a high-throughput lab workflow. We can avoid allelic dropout issues associated with amplicon-based workflows. Based on our own validation, the panel allows us to report clinically actionable results and support treatment decisions.**
Dr. Florian Battke, Director of Development, CeGaT GmbH
**Disclaimer: Results are specific to the institution where they were obtained and may not reflect the results achievable at other institutions.